Trials / Conditions / Subependymal Giant Cell Astrocytoma
Subependymal Giant Cell Astrocytoma
3 registered clinical trials studyying Subependymal Giant Cell Astrocytoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) NCT02654340 | CENTOGENE GmbH Rostock | — |
| Completed | Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma As NCT00789828 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex NCT00411619 | Children's Hospital Medical Center, Cincinnati | Phase 1 / Phase 2 |